Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in…

read more

Fall Advocacy Update: USP 797, E/M Documentation and Payment

Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released…

read more

Brief Update on the Final CY 2019 Physician Fee Schedule

On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/19: Research Grant Cycle
Learn more

02/15/20: Crowdsourcing for 2020 Scottsdale
Learn more

02/15/20: Call for Proposals
Learn more

04/01/20: Fellow Exam Application Deadline
Learn more

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

EDUCATION

Here is What You Missed...

2019 New Orleans was an outstanding success?  With over 500 participants, our AAOA members left New Orleans re-energized, re-freshed, and re-engaged.  The program offered something for everyone — from cutting edge clinical content to every day how to’s for practice management efficiencies. Read More

AAOA in the Lone Star

Join us in the Lone Star State for the 2019 AAOA Advanced Course in Allergy and Immunology. This course builds on the basic clinical care of allergic patient concepts and techniques presented at the AAOA’s Basic Course in Allergy & Immunology. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2019 Advanced Course in Allergy & Immunology
December 12-14 | Austin, TX
Learn More

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
Learn More and Register

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Save the Date

AAOA Clinical Insights
Learn More and Register

NEW!!! USP 797 Online Module
Learn More and Register

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Off to College: Tips for Managing Allergies

Heading to college is an exciting time. What are the best ways for students to avoid exacerbation of their symptoms as they enter the hallowed halls of higher learning?

Read More

College Allergy Symptoms Treatment Back to Shcool

News and Updates

International Forum of Allergy & Rhinology Top Articles 2018-2019

Read top articles published in the International Forum of Allergy & Rhinology 2018-2019. Most Cited International Consensus…

read more

CEO Update – Re·im·ag·ine

re·im·ag·ineverb reinterpret (an event, work of art, etc) imaginatively; rethink Reimagined, Reinvented, Reinvigorated….these are all…

read more

Americans May be Over-diagnosing Themselves with Food Allergies

"Food allergy is a costly, potentially life-threatening health condition that can adversely affect patients’ well-being". A study…

read more

Menu

Your AAOA at the AMA

I want to urge you to consider membership in the AMA because your membership in AMA gives us a voice.

The American Medical Association is one organization that the AAOA works through to advocate for issues related to the AAOA.   As a national specialty society, your membership in the AMA is what gives us our seat — which gives us a voice on your behalf.  This seat goes beyond our AMA House of Delegates delegation.  It gives us a seat at CPT, RUC, and PERC as well.   Without a seat in the AMA, we would not be able to participate in these other regulatory bodies.

Through our involvement in the AMA, we have been able to collaborate with AAAAI and  ACAAI to oppose change in the proposed changes to USP 797 concerning physician allergy compounding that was put forth 2 years ago.  Those joint efforts resulted in halting the change in USP policy and causing USP to revamp recommendations. USP 797 and issues around physician compounding at the FDA are key examples of issues where AAOA’s participation in national coalitions and working with AMA have been instrumental in helping to assure you can deliver quality care.

Through this advocacy effort and the work of our Socioeconomic Committee, we were invited two years ago by the ACAAI leadership to participate on its Advocacy Council of the ACAAI.  Again, broadening our voice and impact on allergy patient care.

Our AMA seat does broaden our opportunities in the House of Medicine.  Networking is key in managing issues at the AMA.  Your AAOA delegation is actively involved in the Chest/Allergy Caucus.  In fact, we will chair this caucus beginning in 2019.  This caucus brings together all the specialties involved in airway management — Chest, Thoracic, Sleep, Allergy, Critical Care, and Pulmonology.  In the House, this caucus has been instrumental in joining forces on issues around physician compounding, tobacco, allergy, food allergy and labeling, over-the-counter medications, and many others.

We also sit on the Otolaryngology Section Council with our peer societies within otolaryngology — AAOHNS, AAFPRS, Triologic, and now ARS — as well as all the otolaryngologists who represent their states in the House of Medicine.  Coalescing these key delegates helps assure specialty interests and state interests are considered together to help achieve better results.

As a specialty society in the AMA House, we have a seat in the Specialty and Service Section, which gives us the opportunity for multiple specialty societies to unite on issues.

The AMA 2018 Interim House of Delegates meeting is just ending in Washington, DC.   Several key issues tied to tobacco, food allergy, CMS, E/M coding, CHIP reauthorization, and more were considered.  The Chest/Allergy caucus was effective in bringing an emergency resolution regarding the FDA’s recent (11/6) decision to put Primatene Mist, an antiquated medication, back on the market as an over-the-counter product to treat mild and intermittent asthma.  While originally pulled due to its delivery mechanism impacting the ozone layer, Primatene Mist, a nonspecific beta agonist or epinephrine, has not been defined as a therapeutic pathway of choice for the management of asthma in any national or international  asthma guideline.  Risk of patient self medication, cardio-vascular risk, and payor issues were all flagged as potential bad, unintended outcomes of pushing Primatene Mist back on the market.  Additionally, issues were raised regarding the FDA process and lack of a public comment period to allow for input, and the AMA will take action with the FDA to urge them to reconsider their decision.

So while you may not always agree with the AMA on issues or want to add yet another dues to your professional costs, our seat is tied to our membership numbers in AMA.  Specialty societies are required to have at least a 20% AMA membership to have a seat.  Your membership in AMA gives us a voice — both on issues with which we agree with AMA and those with which we do not.  Please consider becoming a member of the AMA so we can maintain our seat in the AMA in 2019.

Wes VanderArk, MD, FAAOA
AAOA AMA Delegate